Quick Answer
RXO, Inc. reported Total Revenue of $5.74 billion for fiscal year 2025.
RXO, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.74B +26.2% |
$4.55B +15.9% |
$3.93B -18.1% |
$4.80B +2.3% |
$4.69B +39.7% |
$3.36B |
| Revenue (ASC 606) | $5.74B +26.2% |
$4.55B +15.9% |
$3.93B -18.1% |
$4.80B +2.3% |
$4.69B +39.7% |
$3.36B |
| Net Income | -$100.00M +65.5% |
-$290.00M -7350.0% |
$4.00M -95.7% |
$92.00M -38.7% |
$150.00M +248.8% |
$43.00M |
| Diluted EPS | -$0.59 +72.8% |
-$2.17 -7333.3% |
$0.03 -96.2% |
$0.79 -39.2% |
$1.30 +251.4% |
$0.37 |
| Total Assets | $3.28B -4.0% |
$3.41B +87.1% |
$1.82B -10.1% |
$2.03B -1.8% |
$2.07B | — |
| Cash and Equivalents | $17.00M -51.4% |
$35.00M +600.0% |
$5.00M -94.9% |
$98.00M +237.9% |
$29.00M | — |
| Stockholders Equity | $1.54B -4.4% |
$1.61B +171.4% |
$594.00M +1.2% |
$587.00M -45.1% |
$1.07B +0.2% |
$1.07B +9.1% |
| Operating Income | -$79.00M -41.1% |
-$56.00M -243.6% |
$39.00M -68.3% |
$123.00M -35.9% |
$192.00M +220.0% |
$60.00M |
| Shares Outstanding | 164.16M +1.0% |
162.52M +38.9% |
117.03M +0.5% |
116.40M | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.42B | +36.6% | +0.1% |
| Revenue (ASC 606) | September 30, 2025 | $1.42B | +36.6% | +0.1% |
| Net Income | September 30, 2025 | -$14.00M | +94.2% | -55.6% |
| Diluted EPS | September 30, 2025 | -$0.08 | +95.6% | -60.0% |
| Total Assets | September 30, 2025 | $3.20B | -5.6% | +0.0% |
| Cash and Equivalents | September 30, 2025 | $25.00M | -54.5% | +38.9% |
| Stockholders Equity | September 30, 2025 | $1.58B | -4.4% | -0.5% |
| Operating Income | September 30, 2025 | -$7.00M | +65.0% | — |
| Shares Outstanding | September 30, 2025 | 164.10M | +2.1% | +0.1% |
- RXO, Inc. reported Total Revenue of $5.74 billion for fiscal year 2025.
- RXO, Inc. showed an increase of +26.2% in Total Revenue compared to the prior fiscal year.
- RXO, Inc. reported Revenue (ASC 606) of $5.74 billion for fiscal year 2025.
- RXO, Inc. showed an increase of +26.2% in Revenue (ASC 606) compared to the prior fiscal year.
- RXO, Inc. reported Net Income of -$100.00 million for fiscal year 2025.
- RXO, Inc. showed an increase of +65.5% in Net Income compared to the prior fiscal year.
- RXO, Inc. reported Diluted EPS of $0.59 per share (loss) for fiscal year 2025.
- RXO, Inc. showed an increase of +72.8% in Diluted EPS compared to the prior fiscal year.
- RXO, Inc. reported Total Assets of $3.28 billion for fiscal year 2025.
- RXO, Inc. showed a decrease of -4.0% in Total Assets compared to the prior fiscal year.
- RXO, Inc. reported Cash and Equivalents of $17.00 million for fiscal year 2025.
- RXO, Inc. showed a decrease of -51.4% in Cash and Equivalents compared to the prior fiscal year.
- RXO, Inc. reported Stockholders Equity of $1.54 billion for fiscal year 2025.
- RXO, Inc. showed a decrease of -4.4% in Stockholders Equity compared to the prior fiscal year.
- RXO, Inc. reported Operating Income of -$79.00 million for fiscal year 2025.
- RXO, Inc. showed a decrease of -41.1% in Operating Income compared to the prior fiscal year.
- RXO, Inc. reported Shares Outstanding of 164.16 million shares for fiscal year 2025.
- RXO, Inc. showed an increase of +1.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: